[The treatment of gastrointestinal infections with ciprofloxacin].
The authors have evaluated the efficacy and tolerability of ciprofloxacin, a new broad-spectrum fluor-quinolone, in the therapy of gastrointestinal infections. The authors have studied 24 patients suffering from above-mentioned infections clinically diagnosed (11 microbiologically diagnosed too). All the patients took ciprofloxacin tablets 500 mg b.i.d. for 10 days (average). All the patients were restored to health and the tolerability was excellent.
Ippolito
A
A
Divisione Malattie Infettive, Ospedale Civile di Taranto.
La Gioia
G
G
Matarrese
M
M
Resta
F
F
Angelini
P
P
Ruffo
F
F
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
D002939:Ciprofloxacin